Literature DB >> 9743226

C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries.

J Torzewski1, M Torzewski, D E Bowyer, M Fröhlich, W Koenig, J Waltenberger, C Fitzsimmons, V Hombach.   

Abstract

There is increasing evidence that complement activation may play a role in atherogenesis. Complement proteins have been demonstrated to be present in early atherosclerotic lesions of animals and humans, and cholesterol-induced atherosclerotic lesion formation is reduced in complement-deficient animals. Potential complement activators in atherosclerotic lesions are now a subject matter of debate. C-reactive protein (CRP) is an acute-phase protein that is involved in inflammatory processes in numerous ways. It binds to lipoproteins and activates the complement system via the classic pathway. In this study we have investigated early atherosclerotic lesions of human coronary arteries by means of immunohistochemical staining. We demonstrate here that CRP deposits in the arterial wall in early atherosclerotic lesions with 2 predominant manifestations. First, there is a diffuse rather than a focal deposition in the deep fibroelastic layer and in the fibromuscular layer of the intima adjacent to the media. In this location, CRP frequently colocalizes with the terminal complement complex. Second, the majority of foam cells below the endothelium show positive staining for CRP. In this location, no colocalization with the terminal complement proteins can be observed. Our data suggest that CRP may promote atherosclerotic lesion formation by activating the complement system and being involved in foam cell formation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9743226     DOI: 10.1161/01.atv.18.9.1386

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  92 in total

Review 1.  Microorganisms in the aetiology of atherosclerosis.

Authors:  S A Morré; W Stooker; W K Lagrand; A J van den Brule; H W Niessen
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

2.  The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice.

Authors:  Talat H Malik; Andrea Cortini; Daniele Carassiti; Joseph J Boyle; Dorian O Haskard; Marina Botto
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

Review 3.  C-reactive protein: a critical update.

Authors:  Mark B Pepys; Gideon M Hirschfield
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 4.  C-reactive protein and risk of cardiovascular disease: evidence and clinical application.

Authors:  Paul M Ridker; Shari S Bassuk; Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

5.  C-reactive protein-mediated vascular injury requires complement.

Authors:  Fadi G Hage; Suzanne Oparil; Dongqi Xing; Yiu-Fai Chen; Mark A McCrory; Alexander J Szalai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-25       Impact factor: 8.311

Review 6.  [Cardiovascular manifestations in inflammatory rheumatic diseases].

Authors:  U Lange; J Strunk
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

7.  Genetics of C-reactive protein and complement factor H have an epistatic effect on carotid artery compliance: the Cardiovascular Risk in Young Finns Study.

Authors:  J Jylhävä; C Eklund; T Pessi; O T Raitakari; M Juonala; M Kähönen; J S A Viikari; T Lehtimäki; M Hurme
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 8.  Vein graft failure.

Authors:  Christopher D Owens; Warren J Gasper; Amreen S Rahman; Michael S Conte
Journal:  J Vasc Surg       Date:  2013-10-03       Impact factor: 4.268

9.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.

Authors:  Mi-Kyung Chang; Christoph J Binder; Michael Torzewski; Joseph L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

Review 10.  The role of complement activation in atherosclerosis.

Authors:  Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.